Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)

PARPi, in combination with ionizing radiation, has demonstrated the ability to enhance cellular radiosensitivity in different tumors. The rationale is that the exposure to radiation leads to both physical and biochemical damage to DNA, prompting cells to initiate three primary mechanisms for DNA rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivero Belenchón, Inés, Congregado Ruiz, Carmen Belen, Saez, Carmen, Osman García, Ignacio, Medina López, Rafael Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455664/
https://www.ncbi.nlm.nih.gov/pubmed/37629155
http://dx.doi.org/10.3390/ijms241612978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455664/
https://www.ncbi.nlm.nih.gov/pubmed/37629155
http://dx.doi.org/10.3390/ijms241612978

Ejemplares similares